Company: PTPI
Filing Date: 2025-03-07
Form Type: PRE 14A
Source: 0001104659-25-021794
Chunk: 75

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-07
Form: PRE 14A
Chunk 75
---
 of business on the tenth (10th) day following the day on which notice of the date of the 2025 Annual Meeting was mailed or public
disclosure of the date of the 2025 Annual Meeting was made, whichever first occurs. Proposals that are not received in a timely manner
will not be presented or voted on at the 2025 Annual Meeting. If a proposal is received on time, the proxies that management solicits
for the meeting may still exercise discretionary voting authority on the proposal under circumstances consistent with the proxy rules of
the SEC. All stockholder proposals should directed to the Company’s President and Chief Commercial Officer, Fady Boctor, at 1185
Avenue of the Americas, 3rd Floor, New York, New York 10036.

In addition to satisfying
the requirements under our By-laws, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of
director nominees other than Director nominees must provide notice that sets forth the information required by Rule 14a-19 under
the Exchange Act no later than September 21, 2025 (i.e., the date that is 60 days prior to the anniversary date of the 2024 Annual
Meeting).

<div align='center'>47</div>

Annex A

<div align='center'>CERTIFICATE OF AMENDMENT
OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
PETROS PHARMACEUTICALS, INC.</div>

Petros Pharmaceuticals, Inc.
(the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State
of Delaware, does hereby certify that:

1. The Amended and Restated Certificate of Incorporation
of the Corporation (the “Certificate of Incorporation”) was filed with the Secretary of State of Delaware on December 1,
2020.

2. Resolutions were duly adopted by the Board
of Directors of the Corporation setting forth this proposed Amendment to the Certificate of Incorporation and declaring said amendment
to be advisable and calling for the consideration and approval thereof at a meeting of the stockholders of the Corporation.

3. Resolutions were duly adopted by the Board
of Directors of the Corporation, in accordance with the provisions of the Certificate of Incorporation set forth below, providing that,
effective as of [·], New York time, on [·],
each [·] (#) issued and outstanding shares of the Corporation’s
Common Stock, par value